In the subgroup of early cancer (pT1,2 N0) or locally advanced cancer, the HER-2 status was also a negative predictor for both 5-year DFS and 5-year OS (P < 0.05) (Fig. 2C–F). The gene discussed is ERBB2; the disease is cancer.